OUR METHOD

Kerastem Process.png
 

HAIR GROWTH MARKET

Spend image-2.png

Kerastem focus on early stage hair-loss in males and females

 

$300 million invested in research & development

Kerastem-market-1.png
 
*Source: IBISWORLD Industry Report OD4136: Hair Loss Treatment Manufacturing in the US **Source: 2015 ISHRS: Hair Follicle Stimulation by Stromal Vascular Fraction Enhanced Adipose Transplantation in Baldness, David Perez-Meza, MD, FISHRS 1 Source: …

*Source: IBISWORLD Industry Report OD4136: Hair Loss Treatment Manufacturing in the US **Source: 2015 ISHRS: Hair Follicle Stimulation by Stromal Vascular Fraction Enhanced Adipose Transplantation in Baldness, David Perez-Meza, MD, FISHRS 1 Source: A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men. Olsen EA, Dunlap FE, Funicella T, Koperski JA, Swinehart JM, Tschen EH, Trancik RJ. J Am Acad Dermatol. 2002 Sep;47(3):377-85. 2 Source: Blume-Peytavi U, et al. J Am Acad Dermatol. (2011) 3 Source: Changes in hair weight in men with androgenetic alopecia after treatment with finasteride (1 mg daily): three- and 4-year results. Price VH, Menefee E, Sanchez M, Kaufman KD. J Am Acad Dermatol. 2006 Jul;55(1):71-4. 4 Source: Finasteride in the treatment of men with androgenetic alopecia. Finasteride Male Pattern Hair Loss Study Group. Kaufman KD, Olsen EA, Whiting D, Savin R, DeVillez R, Bergfeld W, Price VH, Van Neste D, Roberts JL, Hordinsky M, Shapiro J, Binkowitz B, Gormley GJ. J Am Acad Dermatol. 1998 Oct;39(4 Pt 1):578-89

 
Kerastem-female-focus.png
 
Kerastem-female-focus-2.png

Market Approvals

 
Study-Progress.png